Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
February 21 2025 - 8:00AM
Edgar (US Regulatory)
Exhibit 1
Transactions in the Securities of the
Issuer During the Past 60 Days
| Nature of the Transaction |
Amount of Securities
Purchased/(Sold) |
Price ($) |
Date of
Purchase/Sale |
WHITEFORT CAPITAL MASTER FUND, LP
| Purchase of Common Stock |
145,684 |
3.1470 |
12/27/2024 |
| Purchase of Common Stock |
130,420 |
3.1893 |
12/30/2024 |
| Purchase of Common Stock |
97,845 |
3.2420 |
12/31/2024 |
| Purchase of Common Stock |
900 |
3.2498 |
01/07/2025 |
| Purchase of Common Stock |
11,826 |
3.2336 |
01/08/2025 |
| Purchase of Common Stock |
45,900 |
3.2498 |
01/10/2025 |
| Purchase of Common Stock |
7,425 |
3.2283 |
01/13/2025 |
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Feb 2024 to Feb 2025
